Primary Care Clinics in Lower Gwynedd, PA Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Springhouse Internal Medicine Internal Medicine Medicare: Medicare Enrolled Practice Location: 605 N Bethlehem Pike, Lower Gwynedd, PA 19002 Phone: 215-643-2119 Fax: 215-643-3568 |
Family Medicine Geriatric And Wellness Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 N Bethlehem Pike, Suite 101, Lower Gwynedd, PA 19002 Phone: 215-540-4411 Fax: 215-540-4415 |
Abington Memorial Hospital Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 605 N Bethlehem Pike, Lower Gwynedd, PA 19002 Phone: 215-540-4411 Fax: 215-540-4415 |
Advocare Ambler Primary Care Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 N Bethlehem Pike Ste 101, Lower Gwynedd, PA 19002 Phone: 215-664-5799 |
Medical Center At Gwynedd Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 605 N Bethlehem Pike, Lower Gwynedd, PA 19002 Phone: 215-643-2403 Fax: 215-643-3568 |
Family Medicine, Geriatrics & Wellness Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 714 N Bethlehem Pike, Ste 101, Lower Gwynedd, PA 19002 Phone: 215-540-4411 Fax: 215-540-4415 |
Michelle Ecker Md Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 Red Barn Rd, Lower Gwynedd, PA 19002 Phone: 267-481-2245 |
News Archive
Russian Ministry of Health approves Medivir's simeprevir for chronic hepatitis C genotype 1 infection
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
Study reveals increase in potency and price of cannabis across Europe
Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe.
Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen
Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach'
Researchers discover two optimal gene targets for new colorectal cancer test
A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation.
› Verified 7 days ago